Neurocrine: Q4 Earnings Snapshot
SAN DIEGO (AP) — SAN DIEGO (AP) — Neurocrine Biosciences Inc. (NBIX) on Wednesday reported fourth-quarter net income of $147.7 million.
The San Diego-based company said it had profit of $1.44 per share.
The results exceeded Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of $1.13 per share.
The biopharmaceutical company posted revenue of $515.2 million in the period, which missed Street forecasts. Twelve analysts surveyed by Zacks expected $519.6 million.
For the year, the company reported profit of $249.7 million, or $2.47 per share. Revenue was reported as $1.89 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NBIX at https://www.zacks.com/ap/NBIX